Ihn H - Search Results

1

Serum levels of matrix metalloproteinase-13 in patients with eosinophilic fasciitis.

Asano Y, Ihn H, Jinnin M, Tamaki Z, Tamaki K, Sato S. Asano Y, et al. Among authors: ihn h. J Dermatol. 2014 Aug;41(8):746-8. doi: 10.1111/1346-8138.12563. Epub 2014 Jul 16. J Dermatol. 2014. PMID: 25041217

2

IL-4 up-regulates the expression of tissue inhibitor of metalloproteinase-2 in dermal fibroblasts via the p38 mitogen-activated protein kinase dependent pathway.

Ihn H, Yamane K, Asano Y, Kubo M, Tamaki K. Ihn H, et al. J Immunol. 2002 Feb 15;168(4):1895-902. doi: 10.4049/jimmunol.168.4.1895. J Immunol. 2002. PMID: 11823524

3

Specific inhibition of human skin fibroblast chemotaxis to platelet-derived growth factor A-chain homodimer by transforming growth factor-beta1.

Soma Y, Mizoguchi M, Yamane K, Yazawa N, Kubo M, Ihn H, Kikuchi K, Tamaki K. Soma Y, et al. Among authors: ihn h. Arch Dermatol Res. 2002 Feb;293(12):609-13. doi: 10.1007/s00403-001-0279-6. Epub 2002 Jan 23. Arch Dermatol Res. 2002. PMID: 11875643

4

Prevalence of 52-kd and 60-kd Ro/SS-A autoantibodies in Japanese patients with polymyositis/dermatomyositis.

Kubo M, Ihn H, Asano Y, Yamane K, Yazawa N, Tamaki K. Kubo M, et al. Among authors: ihn h. J Am Acad Dermatol. 2002 Jul;47(1):148-51. doi: 10.1067/mjd.2002.121037. J Am Acad Dermatol. 2002. PMID: 12077598

5

Increased transcriptional activities of transforming growth factor beta receptors in scleroderma fibroblasts.

Yamane K, Ihn H, Kubo M, Tamaki K. Yamane K, et al. Among authors: ihn h. Arthritis Rheum. 2002 Sep;46(9):2421-8. doi: 10.1002/art.10477. Arthritis Rheum. 2002. PMID: 12355490 Free article.

6

Mitogenic activity of dermatofibrosarcoma protuberans is mediated via an extracellular signal related kinase dependent pathway.

Ihn H, Tamaki K. Ihn H, et al. J Invest Dermatol. 2002 Oct;119(4):954-60. doi: 10.1046/j.1523-1747.2002.00383.x. J Invest Dermatol. 2002. PMID: 12406344 Free article.

7

Upregulated expression of transforming growth factor-beta receptors in dermal fibroblasts of skin sections from patients with systemic sclerosis.

Kubo M, Ihn H, Yamane K, Tamaki K. Kubo M, et al. Among authors: ihn h. J Rheumatol. 2002 Dec;29(12):2558-64. J Rheumatol. 2002. PMID: 12465152

8

The prevalence and clinical significance of anti-U1 RNA antibodies in patients with systemic sclerosis.

Asano Y, Ihn H, Yamane K, Kubo M, Tamaki K. Asano Y, et al. Among authors: ihn h. J Invest Dermatol. 2003 Feb;120(2):204-10. doi: 10.1046/j.1523-1747.2003.12028.x. J Invest Dermatol. 2003. PMID: 12542523 Free article.

9

Epidermal growth factor up-regulates expression of transforming growth factor beta receptor type II in human dermal fibroblasts by phosphoinositide 3-kinase/Akt signaling pathway: Resistance to epidermal growth factor stimulation in scleroderma fibroblasts.

Yamane K, Ihn H, Tamaki K. Yamane K, et al. Among authors: ihn h. Arthritis Rheum. 2003 Jun;48(6):1652-66. doi: 10.1002/art.11029. Arthritis Rheum. 2003. PMID: 12794834 Free article.

10

Antagonistic effects of TNF-alpha on TGF-beta signaling through down-regulation of TGF-beta receptor type II in human dermal fibroblasts.

Yamane K, Ihn H, Asano Y, Jinnin M, Tamaki K. Yamane K, et al. Among authors: ihn h. J Immunol. 2003 Oct 1;171(7):3855-62. doi: 10.4049/jimmunol.171.7.3855. J Immunol. 2003. PMID: 14500687

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

569 results

Search Page

Filters